Literature DB >> 12093671

Responses of adipose and muscle lipoprotein lipase to chronic infection and subsequent acute lipopolysaccharide challenge.

Frédéric Picard1, Denis Arsenijevic, Denis Richard, Yves Deshaies.   

Abstract

Infection of male Swiss Webster mice with Toxoplasma gondii or Neospora caninum leads to long-term alterations in energy balance. Following an initial 20 to 30% weight loss in all T. gondii-infected mice, half of the animals regain most of the lost weight (gainers), whereas the others maintain their low body weight (nongainers). Infection with N. caninum does not elicit weight loss. Lipoprotein lipase (LPL), the enzyme responsible for plasma triglyceride (TG) clearance and partitioning among tissues, is under tissue-specific modulation associated with energy balance. It is also a major determinant of infection-induced hypertriglyceridemia. This study aimed to assess the long-term modulation of adipose and muscle LPL activity in mice infected with T. gondii or N. caninum, to evaluate the effects of subsequent acute lipopolysaccharide (LPS) administration, and to relate LPL modulation in these conditions with infection-related changes in body weight gain. Twenty-eight days after infection, LPL activity in muscle of both gainer and nongainer T. gondii-infected mice was reduced by 40 to 50% compared with the levels in controls and N. caninum-infected mice, whereas LPL activity in adipose depots remained unchanged in all infected groups compared to the level in controls. LPS (from Escherichia coli, 100 ng/kg) injection induced a global reduction in adipose LPL in all groups, as assessed 90 min later. In both T. gondii-infected subgroups, muscle LPL was not further reduced by LPS treatment, whereas it was decreased by 40 to 50% in muscles of control and N. caninum-infected mice. Pre-LPS TG levels in plasma were similar in all groups. LPS greatly increased TG levels in plasma in both control and N. caninum-infected animals, whereas it did not alter those of T. gondii-infected gainer or nongainer animals. These results show that (i) independently of the extent of postinfection weight gain, long-term infection with T. gondii chronically reduces muscle LPL, which becomes unresponsive to acute endotoxemia; (ii) modulation of tissue LPL activity during chronic T. gondii infection favors TG partitioning towards adipose tissue; and (iii) skeletal muscle LPL is a key determinant of the acute response of triglyceridemia to LPS.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12093671      PMCID: PMC120025          DOI: 10.1128/cdli.9.4.771-776.2002

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  49 in total

1.  Nitric oxide mediates endotoxin-induced hypertriglyceridemia through its action on skeletal muscle lipoprotein lipase.

Authors:  F Picard; S Kapur; M Perreault; A Marette; Y Deshaies
Journal:  FASEB J       Date:  2001-08       Impact factor: 5.191

2.  A role for interferon-gamma in the hypermetabolic response to murine toxoplasmosis.

Authors:  D Arsenijevic; F D Bilbao; P Giannakopoulos; L Girardier; S Samec; D Richard
Journal:  Eur Cytokine Netw       Date:  2001 Jul-Sep       Impact factor: 2.737

3.  Activation of the hypothalamo-pituitary-adrenal axis in response to septic or non-septic diseases--implications for the euthyroid sick syndrome.

Authors:  H Mönig; T Arendt; M Meyer; S Kloehn; B Bewig
Journal:  Intensive Care Med       Date:  1999-12       Impact factor: 17.440

4.  Interferon-gamma and interleukin-12 mediate protection to acute Neospora caninum infection in BALB/c mice.

Authors:  T V Baszler; M T Long; T F McElwain; B A Mathison
Journal:  Int J Parasitol       Date:  1999-10       Impact factor: 3.981

5.  Sex differences in regional distribution of fat cell size and lipoprotein lipase activity in morbidly obese patients.

Authors:  S K Fried; J G Kral
Journal:  Int J Obes       Date:  1987

6.  Multiple cytokines stimulate hepatic lipid synthesis in vivo.

Authors:  K R Feingold; M Soued; M K Serio; A H Moser; C A Dinarello; C Grunfeld
Journal:  Endocrinology       Date:  1989-07       Impact factor: 4.736

7.  Epinephrine stimulates human muscle lipoprotein lipase activity in vivo.

Authors:  S B Pedersen; J F Bak; P Holck; O Schmitz; B Richelsen
Journal:  Metabolism       Date:  1999-04       Impact factor: 8.694

8.  Lipoprotein lipase in heart cell cultures is suppressed by bacterial lipopolysaccharide: an effect mediated by production of tumor necrosis factor.

Authors:  G Friedman; R Gallily; T Chajek-Shaul; O Stein; E Shiloni; J Etienne; Y Stein
Journal:  Biochim Biophys Acta       Date:  1988-05-22

9.  Triacylglycerol kinetics in endotoxic rats with suppressed lipoprotein lipase activity.

Authors:  G J Bagby; C B Corll; R R Martinez
Journal:  Am J Physiol       Date:  1987-07

Review 10.  Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases.

Authors:  R H Eckel
Journal:  N Engl J Med       Date:  1989-04-20       Impact factor: 91.245

View more
  4 in total

Review 1.  The Immune Response in Adipocytes and Their Susceptibility to Infection: A Possible Relationship with Infectobesity.

Authors:  Orestes López-Ortega; Nidia Carolina Moreno-Corona; Victor Javier Cruz-Holguin; Luis Didier Garcia-Gonzalez; Addy Cecilia Helguera-Repetto; Mirza Romero-Valdovinos; Haruki Arevalo-Romero; Leticia Cedillo-Barron; Moisés León-Juárez
Journal:  Int J Mol Sci       Date:  2022-05-31       Impact factor: 6.208

2.  Chronic Toxoplasma gondii infection and sleep-wake alterations in mice.

Authors:  Damien Dupont; Jian-Sheng Lin; François Peyron; Hideo Akaoka; Martine Wallon
Journal:  CNS Neurosci Ther       Date:  2021-06-04       Impact factor: 5.243

3.  Toxoplasmosis complications and novel therapeutic synergism combination of diclazuril plus atovaquone.

Authors:  Helieh S Oz
Journal:  Front Microbiol       Date:  2014-09-15       Impact factor: 5.640

4.  Toxoplasmosis, Pancreatitis, Obesity and Drug Discovery.

Authors:  Helieh S Oz
Journal:  Pancreat Disord Ther       Date:  2014-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.